News

Article

Recipharm and Adroit Science Collaborate to Expand Development Services

Adroit Science AB will support Recipharm’s pharmaceutical development with solid-state characterization services.

 

Recipharm AB and Adroit Science AB have formed a new strategic collaboration to expand their service offering. Adroit Science AB will support Recipharm’s pharmaceutical development with solid-state characterization services.  The combination of both companies’ expertise in formulation development, API development, chemical analysis, and solid-state characterization, will improve speed and reduce development costs, while improving quality.

Carl-Johan Spak, executive vice-president, Development & Technology at Recipharm, commented in a press release that the addition of development services from Adroit provides a competitive offering that will help customers to progress their projects more efficiently, including complete development from molecule to product.  Adroit Science AB has established itself as a provider of solid-state characterization services in Northern Europe.

According to Hans Gredeby, CEO of Adroit Science AB, Adroit Science and Recipharm have already cooperated in a number of projects and this partnership marks the next step in the mutual development of both companies’ relationship.

Source: Recipharm

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content